A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety
Clinical trial NCT01712178 · COMPLETED
Trial details
- NCT number
- NCT01712178
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-05-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.